Do Nicotine Pouches Cause Cancer? What the Evidence Shows

By PouchGuide Editorial Team · Published September 25, 2026

“Can nicotine pouches cause mouth cancer?” is one of the most searched questions about ZYN and other pouches. The honest answer has three parts. Pouches contain far fewer cancer-causing chemicals than cigarettes or traditional tobacco. They are not completely free of them. And they haven’t been around long enough for studies to show whether long-term users actually get more cancer.

Here’s what the evidence says so far.

Where cancer risk from tobacco comes from

Most of the cancer risk from smoking and traditional smokeless tobacco doesn’t come from nicotine. It comes from other chemicals, especially tobacco-specific nitrosamines (TSNAs), which form when tobacco leaf is cured and processed. Two of them, NNN and NNK, are among the most potent carcinogens in tobacco and are classified by the International Agency for Research on Cancer (IARC) as carcinogenic to humans. The US National Cancer Institute says smokeless tobacco causes oral, esophageal and pancreatic cancer, that tobacco-specific nitrosamines are its most harmful chemicals, and that nitrosamine levels are directly related to cancer risk.

Nicotine pouches are designed around that problem: they contain nicotine but no tobacco leaf.

Do nicotine pouches contain carcinogens?

Mostly not, but sometimes in small amounts. The key independent study is a 2024 analysis in Tobacco Control by researchers at Germany’s Federal Institute for Risk Assessment. They tested 44 nicotine pouches from 20 manufacturers and found:

• TSNAs were detected in 26 of the products
• the highest level found was 13 nanograms of NNN per pouch

The authors described the presence of carcinogenic TSNAs as “of serious concern” and called for better manufacturing and quality control. The levels are low, since pouches have no tobacco leaf, but they show “tobacco-free” doesn’t guarantee “nitrosamine-free”.

A separate 2023 study in Archives of Toxicology screened pouch flavorings and other ingredients and found three substances classified by IARC as possibly carcinogenic to humans among the 186 substances identified across 50 products. Detecting a substance isn’t the same as showing it causes cancer at the doses involved, but it’s another reason researchers are calling for tighter ingredient rules.

What about nicotine itself?

Nicotine is not classified as a carcinogen by IARC. That doesn’t mean it’s irrelevant to cancer. A 2015 review in Frontiers in Oncology concluded that nicotine may contribute to cancer development by stimulating processes such as cell growth and blood-vessel formation, and noted that in animal studies nicotine enhanced the growth of existing tumors. The authors also said it was not possible to conclude whether nicotine itself can cause cancer on its own, and that more human studies are needed.

In short, nicotine isn’t considered a cause of cancer in the way TSNAs are, but it isn’t proven to be harmless either, especially for someone who already has cancer.

How do pouches compare with cigarettes and dip?

On the evidence available, pouches expose users to far fewer tobacco-related toxicants:

• A 2025 study in Nicotine & Tobacco Research using US national biomarker data found that nicotine pouch users had high nicotine exposure, but much lower levels of tobacco-related markers than smokers. Levels of two minor tobacco alkaloids were 93% and 97% lower, and lead was 50% lower.
• In June 2026, the FDA authorized specific ZYN products to be marketed with a claim that switching completely from cigarettes to ZYN lowers the risk of mouth cancer, lung cancer and several other diseases. See our explainer on what that authorization does and doesn’t mean.

That’s a comparison with cigarettes. It isn’t a statement that pouches carry no cancer risk, and it doesn’t apply to people who never smoked.

The big unknown: long-term use

Modern nicotine pouches have only been widely sold since the late 2010s. Cancers of the mouth and throat typically take many years to develop, so there simply aren’t long-term studies of pouch users yet. Nobody can say with confidence what 20 years of daily pouch use does to cancer risk. See our long-term effects guide for what else is still unknown.

What this means for you

• If you smoke or use dip, switching completely to nicotine pouches very likely cuts your exposure to cancer-causing chemicals by a large margin. Quitting nicotine altogether is still the lowest-risk option.
• If you don’t use nicotine, pouches add risk for no health benefit. Nicotine is addictive, and the long-term cancer picture is unknown.
• If you use pouches, look after your mouth. Rotate where you place pouches, get regular dental check-ups, and see a dentist or doctor about a mouth ulcer that lasts more than 3 weeks, or any red or white patch or lump in your mouth. These are the NHS’s mouth cancer warning signs. See our oral health guide.
• If you’ve had cancer or are being treated for it, talk to your care team about any nicotine use.

Bottom line

Nicotine pouches contain far fewer cancer-causing chemicals than cigarettes or traditional smokeless tobacco, because they have no tobacco leaf. But independent testing has found low levels of tobacco-specific nitrosamines in many products, nicotine may play a supporting role in cancer growth, and there’s no long-term data on cancer in pouch users yet. For smokers, switching completely is very likely a big reduction in risk. For non-users, there’s no reason to start.